Jochem van der Voort van Zyp

Associate Professor - medical

Strategic program(s):

Contact

jvoortva@umcutrecht.nl

Pure profile

Research groups

Prostate cancer, MRI-guided radiotherapy

Research aim

The goal of MR-guided radiotherapy is further improve oncological outcome and reduce treatment related toxicity.

Go to group

Recent publications

All publications

An Overview of Patient-reported Outcomes for Men with Prostate Cancer Sebastiaan Remmers, Katharina Beyer, Tariq A. Lalmahomed, Peter Prinsen, Nicole J.E. Horevoorts, Nora Tabea Sibert, Christoph Kowalski, Francesco Barletta, Oliver Brunckhorst, Giorgio Gandaglia, Jochem R.N. van der Voort van Zyp, Emma J. Smith, Andre Deschamps, Laurence Collette, Philip Cornford, Susan Evans-Axelsson, James N'Dow, Mieke Van Hemelrijck, Monique J. Roobol, Lionne D.F. Venderbos,
European Urology Open Science, 2025, vol. 71, p.106-113

Robotic MR-guided high dose rate brachytherapy needle implantation in the prostate (ROBiNSon)—a proof-of-concept study Marnix J.A. Rasing, Leonard J. van Schelven, Astrid L.H.M.W. van Lier, Ernest Boskovic, Marieke van Son, Rogier I. Schokker, Katelijne M. van Vliet-Van den Ende, Daniëlle D. Kelder, Jacqueline Verkerk, Sandrine M.G. van de Pol, Jan J.W. Lagendijk, Max Peters, Jochem R.N. van der Voort van Zyp, Marinus A. Moerland
Physics in medicine and biology, 2024, vol. 69

Automated pelvic MRI measurements associated with urinary incontinence for prostate cancer patients undergoing radical prostatectomy Ingeborg van den Berg, Robert N Spaans, Frank J Wessels, Erik J R J van der Hoeven, Charlotte J Tutein Nolthenius, Roderick C N van den Bergh, Jochem R N van der Voort van Zyp, Cornelis A T van den Berg, Harm H E van Melick
European radiology experimental, 2024, vol. 8

Overall survival benefit of androgen suppression in addition to dose-escalated external beam radiotherapy for high-risk prostate cancer Berdine L. Heesterman, Katja K.H. Aben, Alfons C.M. van den Bergh, Jochem R.N. van der Voort van Zyp, Leonard P. Bokhorst
Urologic Oncology: Seminars and Original Investigations, 2024, vol. 42, p.245.e9-245.e18

Safety and Tolerability of Online Adaptive High-Field Magnetic Resonance-Guided Radiotherapy Jasmijn M. Westerhoff, Lois A. Daamen, John P. Christodouleas, Erwin L.A. Blezer, Ananya Choudhury, Rosalyne L. Westley, Beth A. Erickson, Clifton D. Fuller, Shaista Hafeez, Uulke A. Van Der Heide, Martijn P.W. Intven, Anna M. Kirby, Susan Lalondrelle, Bruce D. Minsky, Stella Mook, Marlies E. Nowee, Corrie A.M. Marijnen, Kristina M. Orrling, Arjun Sahgal, Christopher J. Schultz, Corinne Faivre-Finn, Robbert J.H.A. Tersteeg, Alison C. Tree, Chia-Lin Tseng, Tine Schytte, Dustin M. Silk, Dave Eggert, Marco Luzzara, Jochem R.N. Van Der Voort Van Zyp, Helena M. Verkooijen, William A. Hall
JAMA network open, 2024, vol. 7

Intra-prostatic recurrences after radiotherapy with focal boost K. Menne Guricová, F. J. Pos, I. G. Schoots, W. V. Vogel, L. G.W. Kerkmeijer, E. M. Monninkhof, J. C.J. de Boer, J. R.N. van der Voort van Zyp, M. Kunze-Busch, R. J. Smeenk, C. Draulans, K. Haustermans, P. J. van Houdt, U. A. van der Heide
Radiotherapy and Oncology, 2024, vol. 201